Ketoconazole in the prevention of acute respiratory distress syndrome

Pharmacotherapy

Volumn 18, Issue 3, 1998, Pages 581-587

  DeVries, Annemarie ^a   Semchuk, William M ^a,b   Betcher, Jeffrey G ^a  

^a Plains Health Centre   (Canada)

^b Saskatchewan Health Authority   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALMITRINE; ANTIOXIDANT; CISAPRIDE; CORTICOSTEROID; CYCLOSPORIN; FIBRONECTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; KETOCONAZOLE; PENTOXIFYLLINE; PHENYTOIN; PROSTAGLANDIN E1; THROMBOXANE SYNTHASE INHIBITOR;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; HUMANS; KETOCONAZOLE; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, ADULT; THROMBOXANE B2;

EID: 0031971025     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-23.
2. Hyers TM. Prediction of survival and mortality in patients with adult respiratory distress syndrome. New Horizons 1993;1(4):466-70.
3. Fowler AA, Hamman RF, Zerbe GO, Benson KN, Hyers TM. Adult respiratory distress syndrome - prognosis after onset. Am Rev Respir Dis 1985;132:472-8.
4. Brandstetter RD, Sharma KC, DellaBadia M, Cabreros LJ, Kabinoff GS. Adult respiratory distress syndrome: a disorder in need of improved outcome. Heart Lung 1997;26:3-14.
5. Hudson LD. New therapies for ARDS. Chest 1995; 108(suppl):79S-91.
6. Slotman GJ, Burchard KW, D'Arezzo A, Gann DS. Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 1988;28(5):648-54.
7. Yu M, Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993;21(11):1635-42.
8. Lamy M, Deby-Dupont G, Deby C, Faymonville M, Damas P. Why is our present therapy for adult respiratory distress syndrome so ineffective? Intensive Crit Care Dig:1992; 11:6-12.
9. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS - definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
10. Montgomery AB, Stoger MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-9.
11. Pepe PE, Potkin RT, Rews DH, et al. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982;144:124-9.
12. Marinelli WA, Ingbar DH. Diagnosis and management of acute lung injury. Clin Chest Med 1994;15(3):517-46.
13. Earl-Salotti GL, Ratzell MD, Maldonado IL. Ketoconazole in the prevention of acute respiratory distress syndrome. J Pharm Technol 1995;11:221-5.
14. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995;273(4);306-9.
15. Gadaleta D, Davis JM. Pulmonary failure and the production of leukotrienes. J Am Coll Surg 1994;178:309-19.
16. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 1995;107:1067-73.
17. Frazee LA, Neidig JA. Ketoconazole to prevent acute respiratory distress syndrome in critically ill patients. Ann Pharmacother 1995;29:784-5.
18. Davis JM, Meyer JD, Barie PS, et al. Elevated production of neutrophil leukotriene B4 precedes pulmonary failure in critically ill surgical patients. Surg Gynecol Obstet 1990;170:495-500.
19. Ulrich H, Kvetan V. Pulmonary support - newer concepts and techniques. Curr Opin Anaesth 1995;8:132-8.
20. Williams JG, Maier RV. Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome). Surgery 1992;112(2):270-7.
21. Beilman G. Ketoconazole for prophylaxis of the adult respiratory distress syndrome [letter]. Crit Care Med 1995;23(4):783-4.
22. Slotman GJ. Ketoconazole: maybe it isn't the magic potion, but... [commentary]. Crit Care Med 1993;21(11):1642-4.
23. Lewis JH, Zimmerman HJ, Benson GD, et al. Hepatic injury associated with ketoconazole therapy. Gastroenterology 1984;86:503-13.
24. Smythe MA, Zarowitz BJ. Changing perspectives of stress gastritis prophylaxis. Ann Pharmacother 1994;28:1073-85.
25. Baciewicz AM, Baciewicz FA. Ketoconazole and fluconazole drug interactions. Arch Intern Med 1993;153:1970-6.
26. Bedford TA, Rowbotham DJ. Cisapride. Drug interactions of clinical significance. Drug Safety 1996;15(3):167-75.